Sentences with phrase «embryonic stem cell treatment»

Federal officials have approved the start of human embryonic stem cell treatment experiments on patients suffering a leading cause of vision loss.

\ n \ nI am very concerned because my Grandson has Spinal Muscular Atrophy and he needs the embryonic stem cell treatment to survive, before he dies.

Not exact matches

The truth, of course, is that there are no human embryonic stem - cell therapies even in clinical trial, let alone ready for therapy, and there have been no major treatment....

research; since most of the reports have concentrated on justifying the creation of cloned human embryos for research into and treatment of neurodegenerative diseases such as Parkinson's, «stem - cells» has become synonymous with «embryonic stem - cells» in the public imagination.

For example, ten or twenty years from now, the physician's tools may include embryonic stem cells or products obtained from cloned embryos and fetuses gestated for that purpose, making physicians who provide such treatments complicit in the life destruction required to obtain the modalities.

Peter Tatchell, human rights campaigner, talked about Catholic dissent from the Pope's hardline, intolerant opposition to liberation theology, women's rights, gay equality, contraception, fertility treatment, embryonic stem cell research and the Pope's collusion with Holocaust deniers and appeasers.

Trials of cells made from human embryonic stem cells are also poised to begin in people with type 1 diabetes and heart failure, the first time embryonic stem cells have been used in the treatment of major lethal diseases.

Decades after they were discovered, human embryonic stem cells are being trialled as a treatment for two major diseases: heart failure and type 1 diabetes

Peter Coffey, a stem - cell biologist at the Institute of Ophthalmology in London, is developing an embryonic - stem - cell treatment for macular degeneration with the global drug company Pfizer.

«It's an exciting development, and we await the outcome over the next year to see how well these cells integrate, and if there are any potential adverse reactions,» says Mike Cheetham of the Institute of Ophthalmology at University College London, one site where research is under way into a human embryonic stem - cell treatment for AMD.

In the past year, the South Korean Food and Drug Administration (FDA) has approved the world's first three stem - cell treatments — Hearticellgram - AMI, Cupistem and Cartistem — which followed on the heels of clinical tests for human embryonic stem - cell therapies approved in 2010, according to the health ministry.

A person with spinal injuries today went down in history as the first to receive a treatment derived from human embryonic stem cells (hESCs).

He has been making that point since 2004, when in testimony to the U.S. Senate, he warned embryonic stem cell opponent Sam Brownback of Kansas, «Those in a position of advice or authority who participate in the banning or enforced delays of biomedical research that could lead to the saving of lives and the amelioration of suffering are directly and morally responsible for the lives made worse or lost due to the ban, or even of a moratorium that would deny such treatments in that short window of time when it could help or save them.»

But even more far - ranging treatments may be possible with embryonic stem cells, the blank - slate cells that give rise to all organs and tissue types and that (theoretically) can repair all forms of organic damage and disease.

Because biologists like Daley are convinced that embryonic stem cells — the most generic, versatile type — may not only lead to dramatically different new treatments but can also uniquely illuminate the origins of disease in a way adult stem cells never will.

The world's first chimeric monkeys were created in a laboratory last year, and they offer surprising new insights into embryonic stem cell therapy: One reason for often - poor treatment outcomes may be that we're using embryos that are, strangely, just too old.

One is a relatively unknown company, CyThera, set up less than 2 years ago in San Diego, that claims to have nine embryonic stem cell lines and is currently trying to develop pancreatic islet cells for treatment of diabetes.

One is using cells derived from human embryonic stem cells to treat spinal cord injury (although funding problems have stopped the trial enrolling new patients) and another is testing a treatment for age - related macular degeneration.

A trial in 18 people with damaged retinal cells is being hailed as the most promising yet for a treatment based on human embryonic stem cells (hESCs).

While the potential of adult stem cells has been understood for some time, researchers have argued that the pluripotency of embryonic stem cells — their ability to be transformed into most if not all of the various cell types of the body — make them more valuable both for research and potentially someday for treatment.

Asked, for instance, whether adult or embryonic stem cell research had yielded any therapeutic results, only 23 % of respondents answered correctly that, to date, only adult stem cells have resulted in treatments for disease.

At present, there are no embryonic stem - cell treatments approved by the US Food and Drug Administration, and most human studies of such therapies have shown unremarkable results.

An eye implant made of a thin sheet of human embryonic stem cells could be considered as an effective treatment for a common form of vision loss.

Tarne demonstrates that funding has moved from grants directed primarily towards embryonic stem cell research toward primarily ethical stem cells research — which has been the only stem cell research to date to result in positive treatments for illnesses.

In July, the FDA released its hold on the first trial of an embryonic stem cell based treatment, for spinal cord injury.

But Hanus and other opponents argued that embryonic stem cells have yet to yield any breakthrough treatments.

There are currently no clinically approved treatments for embryonic stem cells.

According to the National Institutes of Health, most embryonic stem cells come from eggs fertilized for in vitro treatments in a lab, not from eggs fertilized in a women's body.

NEW YORK (AP)-- For only the second time, the U.S. government has approved a test in people of a treatment using embryonic stem cells — this time for a rare disease that causes serious vision loss.

Government regulators have given the go - ahead to a second study that will for the first time carefully test a treatment created using human embryonic stem cells in people, according to the company sponsoring the experiment.

Federal officials have cleared a second clinical trial of a human embryonic stem - cell treatment, a company announced Monday, for a progressive blindness syndrome affecting young people.

For the first time, an experimental treatment made from human embryonic stem cells has shown evidence of helping someone, partially restoring sight to two people suffering from slowly progressing forms of blindness

Frequently lost in the policy discussions about human embryonic stem cells research are concrete realities that will determine how quickly such research will result in treatments and cures.

The challenge takes on even more urgency with recent developments, including a federal administration now more open to exploring the potential of stem cells, the recent FDA approval of a human trial involving embryonic stem cells, as well as the reported case of a young boy who developed a brain tumor four years after receiving a stem - cell treatment for a rare genetic disorder.

Using cloning technology to derive embryonic stem cells genetically identical to a patient is potentially very important, not only to provide a source of cells that may be used to cure patients, but also to allow for genetic disease to be studied and potential drug treatments to be explored in the laboratory.

The first clinical trial treatment based on embryonic stem cells may soon get the go ahead.

Forbes, Robert Langreth, February 20, 2008: In progress toward a stem - cell treatment for diabetes, researchers at a small San Diego biotech company have devised a procedure for turning human embryonic stems cells into insulin - producing cells inside mice.

This experimental treatment for type 1 diabetes combines the Encaptra ™ drug delivery system, which is a semi-permeable pouch, and PEC - 01 ™ cells, pancreatic precursor cells derived from human embryonic stem cells.

Kadimastem's product, AstroRx ® is a human embryonic stem cell (hESC)- based treatment for amyotrophic lateral sclerosis (ALS), based on astrocytes produced from stem cells.

Human embryonic stem cells (hESCs) could serve as an expandable source for neurons production, which could be applied for the treatment of various diseases affecting brain.

It is a technology, which purpose is obtaining embryonic stem cells for research and use in the treatment of various human diseases.

Treatment of perianal fistulas with human embryonic stem cell - derived mesenchymal cells: a canine model of human fistualizing Crohn's disease.

Treatment of canine perianal fistulas with an intralesional injection of human mesenchymal, embryonic - derived stem cells (hE - MSCS), Annual Congress of the European Society of Veterinary Dermatology and European College of Veterinary Dermatology.

Treatment of canine perianal fistulas with an intralesional injection of human mesenchymal, embryonic - derived stem cells (hE - MSCs).